幹細胞的全球市場

Stem Cells

出版日期: 2023年03月01日 | 出版商:

Global Industry Analysts, Inc. | 英文 369 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

幹細胞的全球市場到2030年將達到191億美元

在COVID-19後改變的商務環境中，2022年估算為107億美元的幹細胞的全球市場，在2022年～2030年間預計將以年複合成長率7.4％增長，到2030年達到191億美元的規模。本報告所分析的市場區隔之一的成人幹細胞年複合成長率將記錄7.2％，到分析期間結束時將達到160億美元。考慮疫情過後的復甦，其他的產品類型領域今後8年的年複合成長率修正為8.5％。

美國市場佔32億美元，中國則將以年複合成長率6.8％的速度成長。

美國的幹細胞市場在2022年估算為32億美元。作為世界第2大經濟大國的中國，在2022年～2030年間年複合成長率預計將為6.8％，到2030年達到33億美元的市場規模。其他熱門的地區市場有日本和加拿大，在分析期間的2022年～2030年間預計將各以7％和6％的速度成長。歐洲市場中，德國將以年複合成長率6％成長。

調查對像企業範例

apceth Biopharma GmbH
Athersys Inc.
AVIVA BioSciences Corporation
BioE Inc.
Bone Therapeutics SA
Cesca Therapeutics Inc.
Cryo-Cell International Inc.
Cytori Therapeutics Inc.
ESI BIO
Gamida Cell Ltd.
Holostem Terapie Avanzate
International Stem Cell Corp.
Kangstem Biotech. Ltd.
Lonza Group Ltd.
Mesoblast Ltd.
Neuralstem Inc.
Nuvasive Inc.
OncoMed Pharmaceuticals Inc.
Osiris Therapeutics Inc.
Promethera Biosciences S.A.N.V
Reliance Life Sciences
ReNeuron Group Plc.
Stemcell Technologies Inc.
Stemedica Cell Technologies Inc.
Stempeutics Research Pvt. Ltd.
Takara Bio USA Inc.
TiGenix NV
U.S Stem Cell Inc.
ViaCord

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Stem Cells Market to Reach $19.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Stem Cells estimated at US$10.7 Billion in the year 2022, is projected to reach a revised size of US$19.1 Billion by 2030, growing at aCAGR of 7.4% over the period 2022-2030. Adult Stem Cells, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$16 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Other Product Types segment is readjusted to a revised 8.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.2 Billion, While China is Forecast to Grow at 6.8% CAGR

The Stem Cells market in the U.S. is estimated at US$3.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 6.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7% and 6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6% CAGR.

Select Competitors (Total 233 Featured):

apceth Biopharma GmbH
Athersys Inc.
AVIVA BioSciences Corporation
BioE Inc.
Bone Therapeutics SA
Cesca Therapeutics Inc.
Cryo-Cell International Inc.
Cytori Therapeutics Inc.
ESI BIO
Gamida Cell Ltd.
Holostem Terapie Avanzate
International Stem Cell Corp.
Kangstem Biotech. Ltd.
Lonza Group Ltd.
Mesoblast Ltd.
Neuralstem Inc.
Nuvasive Inc.
OncoMed Pharmaceuticals Inc.
Osiris Therapeutics Inc.
Promethera Biosciences S.A.N.V
Reliance Life Sciences
ReNeuron Group Plc.
Stemcell Technologies Inc.
Stemedica Cell Technologies Inc.
Stempeutics Research Pvt. Ltd.
Takara Bio USA Inc.
TiGenix NV
U.S Stem Cell Inc.
ViaCord

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- Stem Cells - Offering Potential for Breakthrough Therapeutic Discoveries
- Recent Market Activity
- Select Approved Stem Cell Products
- Stem Cells Bypass Use of Animal Models in Drug Discovery Programs
- Trends Related to Stem Cell Clinical Trials
- Select Stem Cell Pipeline Analysis
- Current & Future Analysis
- Stem Cell Research Funding Policies across the World
- Japan and US - Pioneering Induced Pluripotent Stem Cell (iPSC) Research
- Adult Stem Cells Deemed More Ethical, More Research Needed to Increase Clinical Applications
- Dental Mesenchymal Stem Cells - Emergence of a Niche Market
- For-Profit, Unregulated Clinics: The Flipside of Stem Cell Research
- Unproven Therapies Do Online Rounds as Effective Treatment Options - A Cause of Concern
- Stem Cells - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
- Athersys, Inc. (USA)
- Apceth GmbH & Co.KG (Germany)
- AVIVA BioSciences Corporation (USA)
- BioE, Inc. (USA)
- Bone Therapeutics SA (Belgium)
- Cesca Therapeutics, Inc. (USA)
- Cryo-Cell International, Inc. (USA)
- Cytori Therapeutics, Inc. (USA)
- ESI BIO, a Division of BioTime Inc. (USA)
- Gamida Cell Ltd. (Israel)
- Holostem Terapie Avanzate (Italy)
- International Stem Cell Corporation (USA)
- Kangstem Biotech., Ltd. (Korea)
- Lonza Group Ltd (Switzerland)
- Mesoblast Ltd. (Australia)
- Neuralstem, Inc. (USA)
- Nuvasive, Inc. (USA)
- Osiris Therapeutics, Inc. (USA)
- OncoMed Pharmaceuticals, Inc (USA)
- PROMETHERA Biosciences S.A.N.V (Belgium)
- Reliance Life Sciences (India)
- ReNeuron Group Plc. (UK)
- STEMCELL Technologies, Inc. (Canada)
- Stemedica Cell Technologies, Inc (USA)
- Stempeutics Research Pvt. Ltd. (India)
- Takara Bio USA Inc (USA)
- TiGenix NV (Belgium)
- U.S Stem Cell, Inc. (USA)
- ViaCord, LLC (USA)
3. MARKET TRENDS & DRIVERS
- Researchers at UCLA Successfully Develop 3D Lung Organoids using Stem Cells
- Embryonic Stem Cell Gene Nanog Found to Reverse Aging
- Canadian and Dutch Scientists Finds the "Genetic Switch" to Increase Stem Cell Volume from Cord Blood
- The Boston Program Pioneers Cell-based Personalized Diabetes Treatment
- iPSCs Provide Valuable Source for Retinal Transplants and Other Applications
- Albumin-Free Culture of Pluripotent Stem Cells Enables Application in Cardiac Disorders
- Stem Cell Therapy - An Alternative to Orthopedic Surgery in Younger Patients?
- Application of Plant Stem Cells in Cosmetic Treatments - Myths Busted
- Adverse Reactions of Stem Cell-Face Lift Therapy
- Stem Cell-Breast Enhancement
- Other Innovations Using Stem Cells
- New Stem Cell Software & Products
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 2: World 8-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
- TABLE 3: World Recent Past, Current & Future Analysis for Adult Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 4: World 8-Year Perspective for Adult Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 6: World 8-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 8: World 8-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 9: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 10: World 8-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
- TABLE 11: World Stem Cells Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- TABLE 12: USA Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 13: USA 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 14: USA Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 15: USA 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
CANADA
- TABLE 16: Canada Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 17: Canada 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 18: Canada Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 19: Canada 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
JAPAN
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- TABLE 20: Japan Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 21: Japan 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 22: Japan Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 23: Japan 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
CHINA
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- TABLE 24: China Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 25: China 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 26: China Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 27: China 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
EUROPE
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- TABLE 28: Europe Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- TABLE 29: Europe 8-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
- TABLE 30: Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 31: Europe 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 32: Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 33: Europe 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
FRANCE
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- TABLE 34: France Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 35: France 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 36: France Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 37: France 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
GERMANY
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- TABLE 38: Germany Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 39: Germany 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 40: Germany Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 41: Germany 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
ITALY
- TABLE 42: Italy Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 43: Italy 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 44: Italy Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 45: Italy 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
UNITED KINGDOM
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- TABLE 46: UK Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 47: UK 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 48: UK Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 49: UK 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
REST OF EUROPE
- TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 51: Rest of Europe 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 53: Rest of Europe 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
ASIA-PACIFIC
- Stem Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 55: Asia-Pacific 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 57: Asia-Pacific 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030
REST OF WORLD
- TABLE 58: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Product Type - Adult Stem Cells and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 59: Rest of World 8-Year Perspective for Stem Cells by Product Type - Percentage Breakdown of Value Sales for Adult Stem Cells and Other Product Types for the Years 2023 & 2030
- TABLE 60: Rest of World Recent Past, Current & Future Analysis for Stem Cells by Application - Regenerative Medicine and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- TABLE 61: Rest of World 8-Year Perspective for Stem Cells by Application - Percentage Breakdown of Value Sales for Regenerative Medicine and Drug Discovery & Development for the Years 2023 & 2030